Cell Therapeutics, Inc. (Nasdaq:CTIC) previously reported its financial results for the third quarter ended September 30, 2011. "This has been a very exciting quarter for the Company as we move pixantrone one step closer to potential approval in both the U.S. and E.U.," noted James A. Bianco, M.D., CEO of Cell Therapeutics, Inc.

Eline Entertainment Group, Inc. (EEGI.PK) announced that the company has entered into merger discussions with China-based video game designer Vu365. EEGI (www.elineentertainment.com) management feels that this is a significant event that merits reporting to the market.

True 2 Beauty, Inc. (Pinksheets:TRTB), a leading manufacturer and distributor of male sexual potency pills and liquid products in the United States, announced today the "Libigrow" family of products will have much larger production capacity as a result of a private placement of five million dollars.